Objective
Our objective is to create within the Community the ditions for emergence of novel therapeutic approaches to neurodegenerative disease and neurotrauma, which represent an urgent socio-eomic and human need. The NeuroNE sortium (22 academic groups, 6 SMEs and 1 management partner in 9 different countries) will take a multi-disciplinary (functional genomics and proteomics, physiology, chemistry, clinical studies) and multi-faceted (disease mechanisms, biology of cell death and survival, regeneration mechanisms, high-throughput screening, gene- and cell-based therapies) approach to this problem. Among the neurodegenerative diseases, we will focus on Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS). Spinal cord injury (SCI) will be the main model for neurotrauma. NeuroNE brings together investigators from different backgrounds (basic scientists, active clinicians and therapeutically-oriented SMEs) to work at all levels on a given disease: post-genomic science, molecular and cell biology, animal models, therapeutic strategies and clinical studies. Professional project management will provide efficient integration, realization of scientific objectives and knowledge management. Common infrastructures include shared NeuroNE-funded core facilities in 7 centres, while our web-based database will serve as a European depository for biological research tools. Training will be provided at several levels: by a competitive program of multi-centre postdoctoral fellowships, by mobility of NeuroNE scientists to other centres and platforms, and by the organization of summer schools and laboratory open days. To feed back the benefits of integration into EU society, we have involved patient organizations from the start, identified associated research groups who will benefit immediately from our infrastructures, and opened network meetings to identified scientists from emerging research centres.
Fields of science
- medical and health sciencesbasic medicineneurologydementiaalzheimer
- medical and health sciencesmedical biotechnologycells technologiesstem cells
- medical and health sciencesbasic medicineneurologyparkinson
- medical and health sciencesclinical medicinetransplantation
- medical and health sciencesbasic medicineneurologyamyotrophic lateral sclerosis
Keywords
Call for proposal
FP6-2003-LIFESCIHEALTH-I
See other projects for this call
Funding Scheme
NoE - Network of ExcellenceCoordinator
CAMBRIDGE
United Kingdom
See on map
Participants (27)
LAUSANNE
See on map
HEIDELBERG
See on map
GOETTINGEN
See on map
117 LUND
See on map
BASEL
See on map
MILANO
See on map
HAIFA
See on map
PARIS
See on map
MUENCHEN
See on map
STOCKHOLM
See on map
GENEVA 4
See on map
MARTINSRIED
See on map
ULM
See on map
LONDON
See on map
ZWIJNAARDE
See on map
MADRID
See on map
ZURICH
See on map
TORINO
See on map
Case 931 MARSEILLE
See on map
MADRID
See on map
MARSEILLE
See on map
COLOGNE
See on map
PARIS
See on map
PADOVA
See on map
2313 REHOVOT
See on map
CAMBRIDGE
See on map
PARIS
See on map